Algeta to Participate in Upcoming Investor Conferences

Marketwired

OSLO, NORWAY--(Marketwired - May 14, 2013) - Algeta ASA (OSE: ALGETA), a company focusedon thedevelopment of novel targeted cancer therapeutics, announces that membersof itssenior management and investor relations teams will participate in thefollowingupcoming investor conferences:


Bank of America Merrill Lynch Healthcare Conference

Date: 13-16 May 2013

Participants:

Mike Booth (SVP, Communications)

Presentation date & time: Thursday 16 May, 2013, 12:00 noon PDT

Venue: Las Vegas, NV, USA


UBS Global Life Science Conference

Date: 20-22 May 2013

Participants:

Mike Booth (SVP, Communications)

Presentation date & time: Monday 20 May, 2013, 8:30am EDT

Venue: New York City, NY, USA


BioEquity Europe 2013

Date: 22-23 May 2013

Participants:

Mike Booth (SVP, Communications)

Renate Birkeli (IR)

Presentation date & time: Wednesday 22 May, 2013, 3:00pm CET

Venue: Stockholm, Sweden


Deutsche Bank Healthcare Conference

Date: 29-30 May 2013

Participants:

Andrew Kay (President & CEO)

Mike Booth (SVP, Communications)

Presentation date & time: Thursday 30 May, 2013, 11:20am EDT

Venue: Boston, MA, USA


Jefferies Global Healthcare Conference

Date: 3-6 June 2013

Participants:

Gillies O'Bryan-Tear (Chief Medical Officer)

Mike Booth (SVP, Communications)

Presentation date & time: Tuesday 4 June, 2013, 3:30pm EDT

Venue: New York City, NY, USA


Goldman Sachs Healthcare Conference

Date: 11-13 June 2013

Participants:

Jeff Albers (President, Algeta US)

Mike Booth (SVP, Communications)

Presentation date & time: Wednesday 12 June, 2013, 8:40am PDT

Venue: Palos Verdes, CA, USA

Presentations, where applicable, will be available to download atwww.algeta.comfollowing these events.

###

About Algeta

Algeta is a company focused on developing novel targeted therapies forpatientswith cancer based on its alpha-pharmaceutical platform. The Company isheadquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,based inCambridge, MA performing commercial marketing operations in the US. Algetaislisted on the Oslo Stock Exchange (ALGETA.OL). For more informationpleasevisit www.algeta.com.

Algeta to Participate in Upcoming Investor Conferences:http://hugin.info/134655/R/1701405/561725.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright andother applicable laws; and

(ii) they are solely responsible for the content, accuracy andoriginality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1701405]

Contact:
For further information, please contact:

Mike Booth / Renate Birkeli
+47 23 00 67 32
Communications & Corporate Affairs
Email Contact

Media enquiries:
Mark Swallow
+44 207 638 9571
Citigate Dewe Rogerson
Email Contact

Knut Ekern
+47 22 04 82 00
Gambit Hill & Knowlton
Email Contact

Kari Watson
+1 781 235 3060
MacDougall Biomedical Communications
Email Contact

US investor enquiries:
Tricia Swanson
+1 646 378 2953
The Trout Group
Email Contact

Rates

View Comments (0)